CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,230,000 | -23.1% | 500,000 | 0.0% | 4.40% | -23.8% |
| Q2 2021 | $2,900,000 | -8.2% | 500,000 | +11.1% | 5.78% | -17.9% |
| Q1 2021 | $3,159,000 | +163.2% | 450,000 | +80.0% | 7.04% | +74.0% |
| Q4 2020 | $1,200,000 | -17.7% | 250,000 | 0.0% | 4.04% | -15.9% |
| Q3 2020 | $1,458,000 | -38.3% | 250,000 | -28.6% | 4.80% | -20.4% |
| Q2 2020 | $2,363,000 | +6.2% | 350,000 | 0.0% | 6.03% | +61.1% |
| Q1 2020 | $2,226,000 | -14.6% | 350,000 | +40.0% | 3.74% | -51.2% |
| Q4 2019 | $2,607,000 | +165.2% | 250,000 | 0.0% | 7.67% | +332.3% |
| Q3 2019 | $983,000 | -13.3% | 250,000 | +900.0% | 1.78% | +62.2% |
| Q3 2014 | $1,134,000 | – | 25,000 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |